Cellcura ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cellcura ASA Announces New Share Capital Registration in Connection with Share Issue
Cellcura ASA announced that with reference to the stock exchange announcement of December 18, 2012 regarding the conversion of convertible loans, 18,319,745 new shares were issued through conversion of the loans at a subscription price of NOK 0.46. The share capital was increased by NOK 1,831,974.50. The share capital increase was registered with the Register of Business Enterprises on January 31, 2013. Cellcura ASA's new share capital is NOK 6,576,493.60 divided on 65,764,936 shares each with a nominal value of NOK 0.10. The new shares issued are expected to be delivered immediately to the lenders/subscribers' VPS accounts. The new shares will be tradable on delivery.
Latest Key Developments in Medical
- Share this
- Digg this